|
Distribution of metastatic events according to tumor and patient characteristics |
|||
| Number of events/number of cases |
% |
P-value* |
|
|
|
|||
| Age |
|||
| ≤ 60 years |
14/32 |
44 |
0.825 |
| 61–70 years |
17/38 |
45 |
|
| > 70 years |
27/54 |
50 |
|
| Location |
|||
| Stomach |
32/78 |
41 |
0.029 |
| Small intestine |
13/29 |
45 |
|
| Other |
13/17 |
76 |
|
| Mitotic rate |
|||
| < 5 per 50 HPF |
12/62 |
19 |
< 0.001 |
| 5–10 per 50 HPF |
16/27 |
59 |
|
| > 10 per 50 HPF |
30/35 |
86 |
|
| Size |
|||
| < 2 cm |
3/20 |
15 |
< 0.001 |
| 2–5 cm |
8/27 |
30 |
|
| 5–10 cm |
15/35 |
43 |
|
| > 10 cm |
32/42 |
76 |
|
| Gender |
|||
| Male |
26/58 |
45 |
0.721 |
| Female |
32/66 |
48 |
|
| Symptoms |
|||
| Yes |
45/93 |
48 |
0.678 |
| No |
13/31 |
42 |
|
| Tumor risk category |
|||
| Very low |
2/19 |
10 |
< 0.001 |
| Low |
4/19 |
21 |
|
| Intermediate |
5/22 |
23 |
|
| High |
47/64 |
73 |
|
| Condensed risk group# |
|||
| LRG |
11/60 |
18 |
< 0.001 |
| HRG |
47/64 |
73 |
|
|
*Log-rank test # LRG, very low, low, and intermediate groups; HRG, high risk group | |||
Mucciarini et al. BMC Cancer 2007 7:230 doi:10.1186/1471-2407-7-230 |
|||